- Home
- CLLS vs ARL Comparison
CLLS vs ARL Comparison
Compare CLLS & ARL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLLS
- ARL
- Stock Information
- Founded
- CLLS 1999
- ARL 1999
- Country
- CLLS France
- ARL United States
- Employees
- CLLS N/A
- ARL N/A
- Industry
- CLLS Biotechnology: Pharmaceutical Preparations
- ARL Building operators
- Sector
- CLLS Health Care
- ARL Real Estate
- Exchange
- CLLS Nasdaq
- ARL Nasdaq
- Market Cap
- CLLS 240.2M
- ARL 231.0M
- IPO Year
- CLLS 2007
- ARL N/A
- Fundamental
- Price
- CLLS $1.87
- ARL $13.91
- Analyst Decision
- CLLS Buy
- ARL
- Analyst Count
- CLLS 3
- ARL 0
- Target Price
- CLLS $7.00
- ARL N/A
- AVG Volume (30 Days)
- CLLS 93.0K
- ARL 17.7K
- Earning Date
- CLLS 11-04-2024
- ARL 11-07-2024
- Dividend Yield
- CLLS N/A
- ARL N/A
- EPS Growth
- CLLS N/A
- ARL N/A
- EPS
- CLLS N/A
- ARL N/A
- Revenue
- CLLS $36,042,000.00
- ARL $51,029,000.00
- Revenue This Year
- CLLS $271.02
- ARL N/A
- Revenue Next Year
- CLLS $33.48
- ARL N/A
- P/E Ratio
- CLLS N/A
- ARL N/A
- Revenue Growth
- CLLS 46.96
- ARL 0.87
- 52 Week Low
- CLLS $1.70
- ARL $12.51
- 52 Week High
- CLLS $3.77
- ARL $25.96
- Technical
- Relative Strength Index (RSI)
- CLLS 47.58
- ARL 41.73
- Support Level
- CLLS $1.70
- ARL $13.37
- Resistance Level
- CLLS $2.00
- ARL $15.85
- Average True Range (ATR)
- CLLS 0.11
- ARL 0.76
- MACD
- CLLS 0.02
- ARL 0.01
- Stochastic Oscillator
- CLLS 56.67
- ARL 29.26
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC, product candidates in other therapeutic indications.
About ARL American Realty Investors Inc.
American Realty Investors Inc is a real estate company. The company acquires, develops, and owns income-producing residential and commercial real estate properties. Its segment involves the Residential segment and the Commercial segment. The residential segment is engaged in the acquisition, development, ownership, and management of multifamily properties and the Commercial segment is engaged in the acquisition, ownership, and management of commercial real estate properties. Its holdings include apartments, office buildings, retail centers, and parcels of land.